2025, Número 1
<< Anterior Siguiente >>
Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (1)
Dermatomiositis amiopática en el adulto mayor. Un caso inusual
Abundis MEE, Yeverino CSG, Muñoz DAC, Villarreal MDZ, Torres QFJ, Serna PG, Ocampo CJ, Salinas MR, Morales DR
Idioma: Ingles.
Referencias bibliográficas: 14
Paginas: 20-23
Archivo PDF: 159.28 Kb.
RESUMEN
La dermatomiositis (DM) es una enfermedad inflamatoria idiopática
que causa debilidad muscular proximal y simétrica e involucramiento
de la piel. Se observa principalmente en personas entre
40 a 50 años de edad. Entre los subtipos de la enfermedad se
encuentra la variedad amiopática, que es un síndrome raro y complejo
y representa 10% de los casos de DM.
Presentamos un caso inusual de DM del subtipo amiopática en
una mujer de 77 años con múltiples comorbilidades y antecedente
de nueve años de diagnóstico de DM.
REFERENCIAS (EN ESTE ARTÍCULO)
Bailey EE and Fiorentino DF. Amyopathic dermatomyositis:definitions, diagnosis, and management, Curr Rheumatol Rep 2014; 16(12):1-2. Available from: https://pubmed.ncbi.nlm.nih.gov/25366932/.
DeWane ME, Waldman R and Lu J, Dermatomyositis: clinicalfeatures and pathogenesis, J Am Acad Dermatol 2020;82(2):267-81. Available from: https://pubmed.ncbi.nlm.nih.gov/31279808/.
Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U et al., Influence of age on characteristics of polymyositisand dermatomyositis in adults. Medicine (Baltimore)1999; 78(3):139-47. Available from: https://pubmed.ncbi.nlm.nih.gov/10352646/.
Concha JSS, Tarazi M, Kushner CJ, Gaffney RG and Werth VP,The diagnosis and classification of amyopathic dermatomyositis:a historical review and assessment of existing criteria, Br JDermatol 2019; 180(5):1001-6. Available from: https://pubmed.ncbi.nlm.nih.gov/10226772/.
Rodríguez-Tejero A, López-Espadafor B, Montero-Vílchez T, Sánchez-Díaz M, Arias-Santiago S and Molina-Leyva A, Treatmentchallenges in clinically amyopathic dermatomyositis: a caseseries and review of new therapeutic options for skin involvement,Dermatol Ther 2021; 34(3):1-4.
Gerami P, Schope JM, McDonald L, Walling HW and SontheimerRD, A systematic review of adult-onset clinically amyopathicdermatomyositis (dermatomyositis sine myositis): a missinglink within the spectrum of the idiopathic inflammatory myopathies,J Am Acad Dermatol 2006; 54(4):602-3.
Flores-Suárez LF, Morales H, Ángeles A and Kraus A, Druginducedamyopathic dermatomyositis, J Clin Rheumatol2002; 8(1):50-4. Available from: https://pubmed.ncbi.nlm.nih.gov/17039201/.
Tang K, Zhang H and Jin H, Clinical characteristics and managementof patients with clinical amyopathic dermatomyositis:a retrospective study of 64 patients at a tertiary dermatologydepartment, Front Med (Lausanne) 2021; 8:1-4. Available from:https://www.frontiersin.org/.
Callander J, Robson Y, Ingram J and Piguet V. Treatment of clinicallyamyopathic dermatomyositis in adults: a systematic review,Br J Dermatol 2018; 179(6):1248-9. Available from: https://pubmed.ncbi.nlm.nih.gov/27167896/.
Da Silva DM, Patel B and Werth VP, Dermatomyositis: a diagnosticdilemma, J Am Acad Dermatol 2018; 79(2):372-3. Availablefrom: https://www.jaad.org/article/S0190962218300173/fulltext.
Suárez-Ortega S, Puente-Fernández A, Santana-Báez S, Godoy-Díaz D, Serrano-Fuentes M and Sanz-Peláez O, Constitutionalsyndrome: clinical entity or a mixed bag, Rev Med Inst MexSeguro Soc 2013; 51(5):532-5.
Martone AM, Onder G, Vetrano DL, Ortolani E, Tosato M, MarzettiE et al., Anorexia of aging: a modifiable risk factor for frailty,Nutrients 2013; 5(10):4126-30. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820063/.
Christopher-Stine L, Vleugels RA and Amato AA, Clinical manifestationsof dermatomyositis and polymyositis in adults, 2024.Available from: https://medilib.ir/uptodate/show/5159.
Hu T and Vinik O, Dermatomyositis and malignancy, CanadianFamily Physician 2019; 65(6):409-10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738379/.